The Twofold Advantage of the Amorphous Form as an Oral Drug Delivery Practice for Lipophilic Compounds: Increased Apparent Solubility and Drug Flux Through the Intestinal Membrane

被引:66
作者
Dahan, Arik [1 ]
Beig, Avital [1 ]
Ioffe-Dahan, Viktoriya [1 ]
Agbaria, Riad [1 ]
Miller, Jonathan M. [2 ]
机构
[1] Ben Gurion Univ Negev, Dept Clin Pharmacol, Sch Pharm, Fac Hlth Sci, IL-84105 Beer Sheva, Israel
[2] Abbott Labs, Global Pharmaceut Res & Dev, Abbott Pk, IL 60064 USA
关键词
amorphous solid dispersions; intestinal permeability; lipophilic drugs; oral absorption; solubility-permeability interplay; PERMEABILITY INTERPLAY; SOLID DISPERSIONS; ENABLING FORMULATIONS; EFFLUX TRANSPORT; P-GLYCOPROTEIN; SOLUBLE DRUGS; BIOAVAILABILITY; DISSOLUTION; ABSORPTION; SYSTEMS;
D O I
10.1208/s12248-012-9445-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purposes of this study were to assess the efficiency of different nifedipine amorphous solid dispersions (ASDs) in achieving and maintaining supersaturation and to investigate the solubility-permeability interplay when increasing the apparent solubility via ASD formulations. Spray-dried ASDs of nifedipine in three different hydrophilic polymers, hydroxypropyl methylcellulose acetate succinate (HPMC-AS), copovidone, and polyvinylpyrrolidone (PVP), were prepared and characterized by powder X-ray diffraction and differential scanning calorimetry. The ability of these formulations to achieve and maintain supersaturation over 24 h was assessed. Then, nifedipine's apparent intestinal permeability was investigated as a function of increasing supersaturation in the parallel artificial membrane permeability assay model and in the single-pass rat intestinal perfusion model. The efficiency of the different ASDs to achieve and maintain supersaturation of nifedipine was found to be highly polymer dependent; while a dispersion in HPMC-AS enabled supersaturation 20x that of the crystalline aqueous solubility, a dispersion in copovidone enabled 10x, and PVP allowed supersaturation of only 5x that of the crystalline solubility. Nifedipine flux across the intestine from supersaturated solutions was increased, and the apparent intestinal permeability was constant, irrespective of the degree of supersaturation or the polymer being used. In conclusion, while with other solubility-enabling approaches (e.g., surfactants, cyclodextrins, cosolvents), it is not enough to increase the apparent solubility, but to strike the optimal solubility-permeability balance, which limits the chances for successful drug delivery, the amorphous form emerges as a more advantageous strategy, in which higher apparent solubility (i.e., supersaturation) will be readily translated into higher drug flux and overall absorption.
引用
收藏
页码:347 / 353
页数:7
相关论文
共 30 条
[1]   Dissolution and Precipitation Behavior of Amorphous Solid Dispersions [J].
Alonzo, David E. ;
Gao, Yi ;
Zhou, Deliang ;
Mo, Huaping ;
Zhang, Geoff G. Z. ;
Taylor, Lynne S. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 100 (08) :3316-3331
[2]   Understanding the Behavior of Amorphous Pharmaceutical Systems during Dissolution [J].
Alonzo, David E. ;
Zhang, Geoff G. Z. ;
Zhou, Deliang ;
Gao, Yi ;
Taylor, Lynne S. .
PHARMACEUTICAL RESEARCH, 2010, 27 (04) :608-618
[3]   A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[4]   Accounting for the solubility-permeability interplay in oral formulation development for poor water solubility drugs: The effect of PEG-400 on carbamazepine absorption [J].
Beig, Avital ;
Miller, Jonathan M. ;
Dahan, Arik .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2012, 81 (02) :386-391
[5]   Supersaturating Drug Delivery Systems: The Answer to Solubility-Limited Oral Bioavailability? [J].
Brouwers, Joachim ;
Brewster, Marcus E. ;
Augustijns, Patrick .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 98 (08) :2549-2572
[6]   Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs [J].
Dahan, Arik ;
Hoffman, Amnon .
JOURNAL OF CONTROLLED RELEASE, 2008, 129 (01) :1-10
[7]   The Fraction Dose Absorbed, in Humans, and High Jejunal Human Permeability Relationship [J].
Dahan, Arik ;
Lennernas, Hans ;
Amidon, Gordon L. .
MOLECULAR PHARMACEUTICS, 2012, 9 (06) :1847-1851
[8]   The Solubility-Permeability Interplay and Its Implications in Formulation Design and Development for Poorly Soluble Drugs [J].
Dahan, Arik ;
Miller, Jonathan M. .
AAPS JOURNAL, 2012, 14 (02) :244-251
[9]   High-Permeability Criterion for BCS Classification: Segmental/pH Dependent Permeability Considerations [J].
Dahan, Arik ;
Miller, Jonathan M. ;
Hilfinger, John M. ;
Yamashita, Shinji ;
Yu, Lawrence X. ;
Lennernas, Hans ;
Amidon, Gordon L. .
MOLECULAR PHARMACEUTICS, 2010, 7 (05) :1827-1834
[10]   The Solubility-Permeability Interplay in Using Cyclodextrins as Pharmaceutical Solubilizers: Mechanistic Modeling and Application to Progesterone [J].
Dahan, Arik ;
Miller, Jonathan M. ;
Hoffman, Amnon ;
Amidon, Gregory E. ;
Amidon, Gordon L. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 99 (06) :2739-2749